Bg pattern

CEFALEXIN REIWA HEALTHCARE 250 mg ORAL SUSPENSION POWDER

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CEFALEXIN REIWA HEALTHCARE 250 mg ORAL SUSPENSION POWDER

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Cefalexina Reiwa Healthcare 250 mg Powder for Oral Suspension EFG

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Cefalexina Reiwa Healthcare and what is it used for
  2. What you need to know before you take Cefalexina Reiwa Healthcare
  3. How to take Cefalexina Reiwa Healthcare
  4. Possible side effects
  5. Storage of Cefalexina Reiwa Healthcare
  6. Contents of the pack and other information

1. What is Cefalexina Reiwa Healthcare and what is it used for

Cefalexina is an antibiotic. It belongs to a group of antibiotics called cephalosporins.

Antibiotics are used to treat bacterial infections and are not effective against viral infections such as flu or common cold.

It is important to follow the instructions regarding dose, administration interval, and treatment duration indicated by your doctor.

Do not store or reuse this medication. If you have any leftover antibiotic after finishing treatment, return it to the pharmacy for proper disposal. Do not throw medicines down the drain or into the trash.

Cefalexina works by eliminating certain types of bacteria that can cause various types of infections in people. Like all antibiotics, cefalexina is only able to eliminate certain types of bacteria, so it is only suitable for treating certain types of infections.

Cefalexina can be used to treat the following infections in adults:

  • bacterial infection of the ears (otitis media)
  • bacterial infections of the pharynx
  • infections of the lungs and respiratory tract
  • uncomplicated urinary bladder infection (cystitis)
  • uncomplicated kidney and prostate infections
  • uncomplicated skin infections
  • dental infections
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Cefalexina Reiwa Healthcare

Do not take Cefalexina Reiwa Healthcare

  • if you are allergic to cefalexina or any of the other ingredients of this medicine (listed in section 6).
  • if you are allergic (hypersensitive) to the group of antibiotics called cephalosporins.
  • if you have had previous severe and immediate hypersensitivity reactions to penicillin or any other type of beta-lactam.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Cefalexina Reiwa Healthcare:

  • if you have ever had an allergic reaction to cefalexina, cephalosporins, penicillins, or any other medicine.
  • if you develop severe or prolonged diarrhea while taking cefalexina.
  • if you have any kidney disease (you may need a reduced dose)
  • if you have ever developed a severe skin rash, scaling, or blisters and ulcers in the mouth after taking cefalexina or other antibacterial agents.

Tell your doctor if you are going to have blood or urine tests. Cefalexina may interfere with these tests.

Acute generalized exanthematous pustulosis (AGEP) has been reported with the use of cefalexina. AGEP appears at the start of treatment as a red, scaly, and widespread rash with bumps under the skin and blisters accompanied by fever. The most common location is mainly in skin folds, trunk, and upper limbs. The greatest risk of this severe skin reaction occurs during the first week of treatment. If you develop a severe rash or any of these skin symptoms, stop taking cefalexina and contact your doctor or seek immediate medical attention.

Other medicines and Cefalexina Reiwa Healthcare

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription. This is because they may interact with cefalexina.

In particular, consult your doctor or pharmacist if you are using any of the following medicines:

  • probenecid(a medicine used to treat gout). Probenecid may increase the amount of cefalexina in the blood, so you may need a lower dose if you are also taking probenecid.
  • metformin(medicines used to treat diabetes), as cefalexina may increase the amount of metformin in your blood.
  • aminoglycosides, vancomycin, and other cephalosporins(medicines used to treat infections)
  • furosemide(a medicine used to increase urine production).
  • medicines used to treat leukemia.

Effects on laboratory tests

Tell your doctor if you are taking Cefalexina Reiwa Healthcare and are having blood or urine tests, as cefalexina may interfere with the results of these tests.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Ask your doctor or pharmacist for advice before taking any medicine.

Cefalexina Reiwa Healthcare should only be used during pregnancy after a benefit/risk assessment by the doctor, especially during the first trimester.

Driving and using machines

Cefalexina Reiwa Healthcare may cause dizziness, agitation, hallucinations, or confusion, so you should be careful when driving or using machines.

Cefalexina Reiwa Healthcare contains lactose

This medicine contains 1161.1 mg of lactose monohydrate per sachet. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

Cefalexina Reiwa Healthcare contains tartrazine

It may cause allergic-type reactions.

Cefalexina Reiwa Healthcare contains aspartame

This medicine contains 10 mg of aspartame in each sachet. Aspartame is a source of phenylalanine, which may be harmful if you have phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body is unable to eliminate it properly.

Cefalexina Reiwa Healthcare contains sulfites

It may rarely cause severe hypersensitivity reactions and bronchospasm.

3. How to take Cefalexina Reiwa Healthcare

Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

First, invert the sachet and gently tap to loosen the powder, pour into a glass, then add 5 ml of water, shaking until it is suspended. Take the 5 ml of suspension with about 150 ml of water.

The reconstituted suspension is stable for 60 minutes. The reconstituted suspension is yellow in color.

Dose

Use in adults and elderly:

The recommended total daily dose is 1 to 4 g orally, in divided doses.

Most infections can be treated with 500 mg every 8 hours. For skin and soft tissue infections, sore throat (streptococcal pharyngitis), and mild and uncomplicated urinary tract infections (e.g., cystitis), the recommended dose is 250 mg every 6 hours or 500 mg every 12 hours.

For more severe infections, higher doses may be needed. A reduced dose is needed for patients with severe kidney disorders.

If you take more Cefalexina Reiwa Healthcare than you should

If you have taken more Cefalexina Reiwa Healthcare than you should, consult your doctor or pharmacist or go to a hospital immediately.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take Cefalexina Reiwa Healthcare

Do not take a double dose to make up for forgotten doses.

If you stop taking Cefalexina Reiwa Healthcare

Take all the sachets that your doctor has prescribed for you. Do not stop taking them, even if you feel better.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you experience any of the following serious side effects, stop taking this medicine and tell your doctor immediately or go to the emergency department of your nearest hospital:

  • Swelling of the face, lips, tongue, or throat (angioedema). (rare side effect - may affect up to 1 in 1,000 people)
  • A sudden allergic reaction, with difficulty breathing, rash, wheezing, and low blood pressure. (rare side effect)
  • Itchy spots or rash on the arms and legs, or severe skin rash, widespread and with blisters (erythema multiforme, Stevens-Johnson syndrome) (rare side effect).
  • Fever, sore throat, and joint pain accompanied by severe blisters, scaling, and a red rash (toxic epidermal necrolysis) (rare side effect).
  • Severe or prolonged diarrhea. This could be a symptom of a more serious illness (pseudomembranous colitis) (rare side effect).

The following side effects have also been reported:

Common side effects(may affect up to 1 in 10 people)

  • Nausea and diarrhea.

Uncommon side effects(may affect up to 1 in 100 people)

  • Changes in blood tests that check how your liver is working.
  • Increased levels of certain types of white blood cells.
  • Rash, hives, and itching.

Rare side effects(may affect up to 1 in 1,000 people)

  • Blood disorders: decrease in the number of different cells in the blood (symptoms may include new infections and easy bruising or bleeding), including the small cells needed for blood clotting; hemolytic anemia, a type of anemia that can be severe and is caused by the rupture of red blood cells.
  • Headache, dizziness.
  • Abdominal pain, vomiting, indigestion.
  • Kidney inflammation.
  • Genital and anal itching and vaginal inflammation (vaginitis).
  • Fatigue.
  • Liver inflammation and yellowing of the skin and eyes (jaundice).

Frequency not known(frequency cannot be estimated from the available data)

  • Urinalysis results for sugar and the Coombs test may be affected.
  • Pain or inflammation of the joints.
  • Infections caused by other germs (e.g., vaginal candidiasis may occur).
  • Hallucinations, agitation, confusion.
  • Red, scaly, and widespread rash with bumps under the skin and blisters accompanied by fever at the start of treatment (acute generalized exanthematous pustulosis). Stop taking cefalexina if you develop these symptoms and contact your doctor or seek immediate medical attention. See also section 2.

If you experience any side effect, talk to your doctor or pharmacist. This includes any possible side effect not listed in this leaflet.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Vigilance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Cefalexina Reiwa Healthcare

Keep this medicine out of the sight and reach of children.

This medicine does not require any special storage temperature.

Keep in the original packaging to protect from light.

Do not use this medicine after the expiry date stated on the carton after EXP. The expiry date is the last day of the month stated.

Do not use this medicine if you notice visible signs of deterioration.

Medicines should not be disposed of via wastewater or household waste. Place the sachets and medicines you no longer need in the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of sachets and medicines you no longer need. This will help protect the environment.

6. Contents of the pack and other information

Composition of Cefalexina Reiwa Healthcare

  • The active substance is cefalexina. Each sachet contains 250 mg of cefalexina (equivalent to 263 mg of cefalexina monohydrate).
  • The other ingredients are:

Lactose monohydrate

Hypromellose 2910

Yellow powder 5 of FD&C (tartrazine E102)

Strawberry flavor

Raspberry flavor

Tutti Frutti flavor

Aspartame

Colloidal anhydrous silica 200

Talc

Appearance of the product and contents of the pack

Cefalexina Reiwa Healthcare is a dry, flavored powder with a white to yellowish color.

The powder is packaged in paper and aluminum sachets. Each carton contains 12 sachets.

Marketing authorization holder

Reiwa Healthcare S.L

Carretera de Fuencarral, 22

28108 – Alcobendas

Madrid

Spain

Manufacturer

Netpharmalab Consulting Services S.L

Carretera de Fuencarral, 22

28108 – Alcobendas

Madrid

Spain

This medicine is authorized in the Member States of the European Economic Area under the following names:

Hungary: Cefalexin Reiwa Healthcare 250 mg por belsoleges szuszpenzióhoz

Germany: Cefalexin Reiwa Healthcare 250 mg Pulver zur Herstellung einer Suspension zum Einnehmen

Spain: Cefalexina Reiwa Healthcare 250 mg polvo para suspensión oral EFG

Date of last revision of this leaflet: March 2022

Other sources of information

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)

Online doctors for CEFALEXIN REIWA HEALTHCARE 250 mg ORAL SUSPENSION POWDER

Discuss questions about CEFALEXIN REIWA HEALTHCARE 250 mg ORAL SUSPENSION POWDER, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for CEFALEXIN REIWA HEALTHCARE 250 mg ORAL SUSPENSION POWDER?
CEFALEXIN REIWA HEALTHCARE 250 mg ORAL SUSPENSION POWDER requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in CEFALEXIN REIWA HEALTHCARE 250 mg ORAL SUSPENSION POWDER?
The active ingredient in CEFALEXIN REIWA HEALTHCARE 250 mg ORAL SUSPENSION POWDER is cefalexin. This information helps identify medicines with the same composition but different brand names.
Who manufactures CEFALEXIN REIWA HEALTHCARE 250 mg ORAL SUSPENSION POWDER?
CEFALEXIN REIWA HEALTHCARE 250 mg ORAL SUSPENSION POWDER is manufactured by Reiwa Healthcare S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of CEFALEXIN REIWA HEALTHCARE 250 mg ORAL SUSPENSION POWDER online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CEFALEXIN REIWA HEALTHCARE 250 mg ORAL SUSPENSION POWDER is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to CEFALEXIN REIWA HEALTHCARE 250 mg ORAL SUSPENSION POWDER?
Other medicines with the same active substance (cefalexin) include CEFALEXIN REIWA HEALTHCARE 500 mg HARD CAPSULES, KEFLORIDINA FORTE 500 mg HARD CAPSULES, CEFADROXIL DESGEN 500 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media